National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meetings, 31953 [2013-12529]
Download as PDF
<![CDATA[
mstockstill on DSK4VPTVN1PROD with NOTICES
Federal Register / Vol. 78, No. 102 / Tuesday, May 28, 2013 / Notices
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Sheraton Silver Spring Hotel, 8777
Georgia Avenue, Silver Spring, MD 20910.
Contact Person: Zhuqing Li, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institutes of Health/NIAID, 6700B
Rockledge Drive, MSC 7616, Bethesda, MD
20892–7616, 301–402–9523,
zhuqing.li@nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Clinical Trials Units for
NIAID Networks.
Date: June 18, 2013.
Time: 8:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 235,
6700A Rockledge Drive, Bethesda, MD
20817, (Telephone Conference Call).
Contact Person: Sujata Vijh, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
NIAID/NIH/DHHS, 6700B Rockledge Drive,
MSC 7616, Bethesda, MD 20892, 301–594–
0985, vijhs@niaid.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Clinical Trials Unit for
NIAID Networks NIAID.
Date: June 18, 2013.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 1205,
6700B Rockledge Drive, Bethesda, MD 20817,
(Telephone Conference Call).
Contact Person: Uday K. Shankar, Ph.D.,
MSC, Scientific Review Officer, Scientific
Review Program, DEAS/NIAID/NIH/DHHS,
6700B Rockledge Drive, MSC 7616, Bethesda,
MD 20892–7616, 301–594–3193,
uday.shankar@nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Clinical Trials Units for
NIAID Networks.
Date: June 19, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 2C21/
23, 10401 Fernwood Road, Bethesda, MD
20817, (Telephone Conference Call).
Contact Person: Raymond R. Schleef,
Ph.D., Scientific Review Officer, Scientific
Review Program, Division of Extramural
Activities, National Institutes of Health/
NIAID, 6700B Rockledge Drive, MSC 7616,
Bethesda, MD 20892–7616, (301) 451–3679,
schleefrr@niaid.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Clinical Trials Units for
NIAID Networks.
Date: June 19, 2013.
Time: 9:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 235,
6700A Rockledge Drive, Bethesda, MD
20817, (Telephone Conference Call).
VerDate Mar<15>2010
17:46 May 24, 2013
Jkt 229001
31953
Contact Person: Sujata Vijh, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
NIAID/NIH/DHHS, 6700B Rockledge Drive,
MSC 7616, Bethesda, MD 20892, 301–594–
0985, vijhs@niaid.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Clinical Trials Unit for
NIAID Networks.
Date: June 20, 2013.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 2C21/
23, 10401 Fernwood Rd., Bethesda, MD
20817, (Telephone Conference Call).
Contact Person: Uday K. Shankar, Ph.D.,
MSC, Scientific Review Officer, Scientific
Review Program, DEAS/NIAID/NIH/DHHS,
6700B Rockledge Drive, MSC 7616, Bethesda,
MD 20892–7616, 301–594–3193,
uday.shankar@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Boulevard, Bethesda, MD 20892, (Virtual
Meeting).
Contact Person: Manana Sukhareva, Ph.D.,
Scientific Review Officer, National Institute
of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707
Democracy Boulevard, Suite 959, Bethesda,
MD 20892, 301–451–3397,
sukharem@mail.nih.gov.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel; 2013/10 NIBIB R13
Conference Grant Meeting.
Date: July 9, 2013.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 920, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Virtual
Meeting).
Contact Person: Steven J. Zullo, Scientific
Review Officer, National Institutes of Health/
NIBIB, Division of Discovery Science and
Technology, 6707 Democracy Blvd./Room
227, Bethesda, MD 20892, 301–451–4774,
Steven.zullo@nih.gov.
Dated: May 21, 2013.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
Dated: May 21, 2013.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–12528 Filed 5–24–13; 8:45 am]
[FR Doc. 2013–12529 Filed 5–24–13; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meetings
National Human Genome Research
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel; MSM Program
Review.
Date: June 27, 2013.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, Suite 951, 6707 Democracy
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel; SEP–UDN Coordinating Center.
Date: June 27, 2013.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Human Genome Research
Institute, 3rd Floor Conference Room, 3146,
5635 Fishers Lane, Rockville, MD,
(Telephone Conference Call).
E:\FR\FM\28MYN1.SGM
28MYN1
]]>Agencies
[Federal Register Volume 78, Number 102 (Tuesday, May 28, 2013)]
[Notices]
[Page 31953]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-12529]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical Imaging and Bioengineering;
Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Biomedical Imaging and
Bioengineering Special Emphasis Panel; MSM Program Review.
Date: June 27, 2013.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, Suite
951, 6707 Democracy Boulevard, Bethesda, MD 20892, (Virtual
Meeting).
Contact Person: Manana Sukhareva, Ph.D., Scientific Review
Officer, National Institute of Biomedical Imaging and
Bioengineering, National Institutes of Health, 6707 Democracy
Boulevard, Suite 959, Bethesda, MD 20892, 301-451-3397,
sukharem@mail.nih.gov.
Name of Committee: National Institute of Biomedical Imaging and
Bioengineering Special Emphasis Panel; 2013/10 NIBIB R13 Conference
Grant Meeting.
Date: July 9, 2013.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 920,
6707 Democracy Boulevard, Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Steven J. Zullo, Scientific Review Officer,
National Institutes of Health/NIBIB, Division of Discovery Science
and Technology, 6707 Democracy Blvd./Room 227, Bethesda, MD 20892,
301-451-4774, Steven.zullo@nih.gov.
Dated: May 21, 2013.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-12529 Filed 5-24-13; 8:45 am]
BILLING CODE 4140-01-P
